Reducing or eliminating the clinical burden associated with the debilitating long-term complications of diabetes has long been a goal of management of this disease. A new study, published in the New England Journal of Medicine, suggests that we are closer to achieving this goal than previously thought.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Predicting adverse outcomes due to diabetes complications with machine learning using administrative health data
npj Digital Medicine Open Access 12 February 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gregg, E. W. et al. Changes in diabetes-related complications in the United States, 1990–2010. N. Engl. J. Med. 370, 1514–1523 (2014).
[No authors listed] The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 329, 977–986 (1993).
[No authors listed] Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 317, 703–713 (1998).
Colhoun, H. M. et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364, 685–696 (2004).
Gaede, P. et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 348, 383–393 (2003).
Booth, G. L., Kapral, M. K., Fung, K. & Tu, J. V. Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care 29, 32–37 (2006).
Lind, M. et al. Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study. Diabetologia 56, 2601–2608 (2013).
Ali, M. K. et al. Achievement of goals in US diabetes care, 1999–2010. N. Engl. J. Med. 368, 1613–1624 (2013).
Lipscombe, L. L., Shah, B. R., Hux, J. E., Austin, P. & Booth, G. L. Income-related differences in mortality among people with diabetes mellitus. CMAJ 182, E1–E17 (2010).
Grant, R. W., McCarthy, E. P., Singer, D. E. & Meigs, J. B. Frequent outpatient contact and decreasing medication affordability in patients with diabetes from 1997 to 2004. Diabetes Care 29, 1386–1388 (2006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Booth, G., Zinman, B. Progress in reducing vascular complications of diabetes. Nat Rev Endocrinol 10, 451–453 (2014). https://doi.org/10.1038/nrendo.2014.90
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2014.90
This article is cited by
-
Predicting adverse outcomes due to diabetes complications with machine learning using administrative health data
npj Digital Medicine (2021)